Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4866 Spu-106
Novel specific PAK4 inhibitor, effectively inhibiting the invasion of SGC7901 cells without cytotoxicity, regulating the PAK4/LIMK1/cofilin and PAK4/SCG10 signaling pathways
More description
DCC4865 Sptssb-binder-18
Novel potent and selective binder of small subunit B of the serine palmitoyltransferase complex (SPTSSB)
More description
DCC4864 Spt-in-1
Novel potent serine palmitoyl transferase (SPT) inhibitor
More description
DCC4863 Spop-in-6lc
Novel SPOP inhibitor, suppressing the viability and inhibiting the colony formation of ccRCC cell lines driven by cytoplasmic SPOP
More description
DCC4862 Spongosine
Pivotal intercellular signal transmitter
More description
DCC4861 spongiacidin C
USP7 inhibitor from the marine sponge Stylissa massa
More description
DCC4860 Spmtrien
Novel isosteric charge-deficient spermine analogue
More description
DCC4859 Spla2 Inhibitor Pyr-1
Novel potent sPLA2 inhibitor, selectively targeting hGIIA and hGIID
More description
DCC4858 Spiroxamine
Sterol Biosynthesis Inhibitor, Fungicide
More description
DCC4857 Spirooxindole 1a
Novel p53 Stabilizer for Brain Cell Differentiation
More description
DCC4856 Spirohydantoin-21
Novel selective orally bioavailable inhibitor of p300/CBP histone acetyltransferase
More description
DCC4855 Spi-1865
Novel gamma-secretase modulator
More description
DCC4854 Spectinomycin Dihydrochloride
Antibiotic, binding to the bacterial 30S ribosomal subunit, interfering with the initiation of protein synthesis and with proper protein elongation and leading to bacterial cell death
More description
DCC4853 Spectinamide-1599
Novel anti-tuberculosis agent against intracellular Mycobacterium tuberculosis
More description
DCC4852 Spd-2-am
Novel photo-controllable hydrogen sulfide donor applicable in live cells
More description
DCC4851 SPB08007
DCC4850 spb03924
Novel telomerase inhibitor
More description
DCC4849 Spam (signal Peptide-based Affinity Maturated Ligand)
Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)
More description
DCC4848 Sortin3 Maleate
Sorting inhibitor, blocking Vps16 function, one protein in the class C tethering complex, and increasing aflatoxin synthesis and export
More description
DCC4847 sori-9804
Novel partial inhibitor of amphetamine-induced dopamine release
More description
DCC4846 sori-20041
DAT modulator, being unique in affecting substrate uptake without impacting efflux
More description
DCC4845 soraphinol A
Human norepinephrine transporter blocker
More description
DCC4844 Sophoraflavanone B
Natural inhibitor of the Kv1.3 channels in a concentration-dependent manner
More description
DCC4843 Sophorafavanone A
Inhibitor of constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase
More description
DCC4842 Sophoradin
Natural analgesic, antipyretic, anti-inflammatory, and anti-tumor agent
More description
DCC4841 Sonedenoson
A2A adenosine receptor agonist
More description
DCC4840 Somcl-863
Novel, selective and orally bioavailable c-Met inhibitor, exhibiting antitumor activity both in vitro and in vivo
More description
DCC4839 Somcl-668
Novel potent and selective allosteric modulator of sigma-1 receptor
More description
DCC4838 Somatoprim
Unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reducing GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours.
More description
DCC4837 Somapacitan
Novel long-acting, reversible albumin-binding growth hormone (GH) derivative for treatment of growth hormone dificiency
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X